Kras G12c Mutant Advanced Solid Tumors clinical trials

Explore recruiting kras g12c mutant advanced solid tumors clinical trials.

Recruiting kras g12c mutant advanced solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kras G12c Mutant Advanced Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

LOXO-RAS-20001; A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase 1/2 Open-label Study of BMS-986466 in Combination with Adagrasib with or without Cetuximab in Participants with KRAS G12C-mutant Advanced Solid Tumors

Spain, Finland, France, Italy, Belgium

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination with Cetuximab, in Participants with KRAS G12C-Mutant, Advanced Solid Tumors (KANDLELIT-014)

Norway, Spain, Sweden, Italy, Denmark, France +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Kras G12c Mutant Advanced Solid Tumors trials by city

Kras G12c Mutant Advanced Solid Tumors in Toronto Kras G12c Mutant Advanced Solid Tumors in Vancouver Kras G12c Mutant Advanced Solid Tumors in Montreal Kras G12c Mutant Advanced Solid Tumors in Calgary Kras G12c Mutant Advanced Solid Tumors in Edmonton Kras G12c Mutant Advanced Solid Tumors in Ottawa Kras G12c Mutant Advanced Solid Tumors in Winnipeg Kras G12c Mutant Advanced Solid Tumors in Quebec City Kras G12c Mutant Advanced Solid Tumors in Hamilton Kras G12c Mutant Advanced Solid Tumors in Kitchener Kras G12c Mutant Advanced Solid Tumors in London Kras G12c Mutant Advanced Solid Tumors in Halifax Kras G12c Mutant Advanced Solid Tumors in New York Kras G12c Mutant Advanced Solid Tumors in Los Angeles Kras G12c Mutant Advanced Solid Tumors in Chicago Kras G12c Mutant Advanced Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease